Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without NPM1 Mutations

Freeman, SD; Hills, RK; Virgo, P; Khan, N; Couzens, S; Dillon, R; Gilkes, A; ... Russell, NH; + view all Freeman, SD; Hills, RK; Virgo, P; Khan, N; Couzens, S; Dillon, R; Gilkes, A; Upton, L; Nielsen, OJ; Cavenagh, JD; Jones, G; Khwaja, A; Cahalin, P; Thomas, I; Grimwade, D; Burnett, AK; Russell, NH; - view fewer (2018) Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without NPM1 Mutations. Journal of Clinical Oncology , 36 (15) pp. 1486-1497. 10.1200/JCO.2017.76.3425 .

https://ift.tt/2kk1YMk